{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:40:18Z","timestamp":1789623618400,"version":"build-2803163510"},"reference-count":7,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Dermatol"],"DOI":"10.1111\/bjd.18234","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T06:44:17Z","timestamp":1561013057000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Safety and efficacy of topical formulations containing 0\u00b75, 1 and 2% glycopyrronium bromide in patients with primary axillary hyperhidrosis: a randomized, double\u2010blind, placebo\u2010controlled study"],"prefix":"10.1093","author":[{"given":"C.","family":"Masur","sequence":"first","affiliation":[{"name":"Dr. August Wolff GmbH & Co. KG Arzneimittel Bielefeld Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2594-9901","authenticated-orcid":false,"given":"M.","family":"Soeberdt","sequence":"additional","affiliation":[{"name":"Dr. August Wolff GmbH & Co. KG Arzneimittel Bielefeld Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kilic","sequence":"additional","affiliation":[{"name":"Dr. August Wolff GmbH & Co. KG Arzneimittel Bielefeld Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Knie","sequence":"additional","affiliation":[{"name":"Dr. August Wolff GmbH & Co. KG Arzneimittel Bielefeld Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7778-7740","authenticated-orcid":false,"given":"C.","family":"Abels","sequence":"additional","affiliation":[{"name":"Dr. August Wolff GmbH & Co. KG Arzneimittel Bielefeld Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,9]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00403-016-1697-9","article-title":"Hyperhidrosis: an update on prevalence and severity in the United States","volume":"308","author":"Doolittle J","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"e_1_2_3_3_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000351292","article-title":"Prevalence and disease burden of hyperhidrosis in the adult population","volume":"227","author":"Augustin M","year":"2013","journal-title":"Dermatology"},{"key":"e_1_2_3_4_1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaad.2018.07.002","article-title":"Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: results from the ATMOS\u20101 and ATMOS\u20102 phase 3 randomized controlled trials","volume":"80","author":"Glaser DA","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_3_5_1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40257-018-0395-0","article-title":"Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: patient\u2010reported outcomes from the ATMOS\u20101 and ATMOS\u20102 phase III randomized controlled trials","volume":"20","author":"Pariser DM","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"e_1_2_3_6_1","article-title":"DRM04 for the treatment of primary axillary hyperhidrosis: primary results from the ATMOS\u20101 and ATMOS\u20102 phase 3 randomized controlled trials","volume":"76","author":"Pariser R","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_3_7_1","unstructured":"Qbrexza.Highlights of prescribing information. Revised June 2018. Available at:https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210361lbl.pdf(accessed 12 March 2019)."},{"key":"e_1_2_3_8_1","first-page":"10","article-title":"Anonymous. Qbrexza \u2013 a glycopyrronium cloth for axillary hyperhidrosis","volume":"61","year":"2019","journal-title":"Med Lett Drugs Ther"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.18234","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.18234","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.18234","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.18234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:50:48Z","timestamp":1676382648000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/182\/1\/229\/6731351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":7,"alternative-id":["10.1111\/bjd.18234"],"URL":"https:\/\/doi.org\/10.1111\/bjd.18234","archive":["Portico"],"relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"2019-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"bjd.18234"}}